Official Certification & Research Support

In today’s variable Regenerative Science and exosome market, Lai Yi Biotech adheres to 100% human-derived, non-animal exosome technology, validated through multiple clinical trials and safety tests, demonstrating strong international application potential. Our R&D achievements have received core government research grants and authoritative certifications in Taiwan, highlighting Lai Yi’s leadership in scientific rigor and regulatory compliance.

All exosome materials are sourced from legally certified cell banks and fully comply with TFDA GTP (Good Tissue Practice) standards. They undergo rigorous testing for sterility, endotoxins, and mycoplasma, minimizing risks associated with animal or unknown sources and ensuring full compliance with international regulations and market standards.

Core Advantages of PRP:

1

Collaboration with Agricultural Technology Research Institute / Industrial Technology Research Institute

Covers cell sourcing, process development, stability control, and efficacy validation, creating a complete product technology cycle.

2

National Science and Technology Council – Research Institution Certification

Recognized for advanced R&D, innovation, and industry-academia impact; eligible for national and international research programs.

3

National Science and Technology Council – Research Institution Certification

Recognized for advanced R&D, innovation, and industry-academia impact; eligible for national and international research programs.

4

National Development Fund Research Support

Approved as a national-level key research program with high tech content and strong commercial potential.

5

Ministry of Science and Technology – Biotech/Regenerative Science Qualification

Part of Taiwan’s national biotech innovation system; clinical-level potential; enjoys tax and policy support.